March 01, 1998; 50 (3) Expedited Publication
Vigabatrin-associated retinal cone system dysfunction
Electroretinogram and ophthalmologic findings
Gregory L. Krauss, Mary A. Johnson, Neil R. Miller
First published March 1, 1998, DOI: https://doi.org/10.1212/WNL.50.3.614
Gregory L. Krauss
Mary A. Johnson
Vigabatrin-associated retinal cone system dysfunction
Electroretinogram and ophthalmologic findings
Gregory L. Krauss, Mary A. Johnson, Neil R. Miller
Neurology Mar 1998, 50 (3) 614-618; DOI: 10.1212/WNL.50.3.614
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 50 no. 3 614-618
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published March 1, 1998.
Copyright & Usage:
© 1998
Author Disclosures
- Gregory L. Krauss, MD,
- Mary A. Johnson, PhD and
- Neil R. Miller, MD
- Gregory L. Krauss, MD,
- Mary A. Johnson, PhD and
- Neil R. Miller, MD
- From the Department of Neurology (Drs. Krauss and Miller), Johns Hopkins University; Maryland Center for Eye Care (Dr. Johnson), University of Maryland; and Neuro-Ophthalmology Unit (Dr. Miller), Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD.
- Address correspondence and reprint requests to Dr. Gregory L. Krauss, Meyer 2-147, 600 N. Wolfe St., Baltimore, MD 21287.
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Visual dysfunction in patients receiving vigabatrinClinical and electrophysiologic findingsN.R. Miller, M.A. Johnson, S.R. Paul et al.Neurology, December 01, 1999 -
Articles
Outer retinal dysfunction in patients treated with vigabatrinC.F. Arndt, P. Derambure, S. Defoort-Dhellemmes et al.Neurology, April 01, 1999 -
Articles
Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defectsR. Kälviäinen, I. Nousiainen, M. Mäntyjärvi et al.Neurology, September 01, 1999 -
Article
Retinal defect in children with infantile spasms of varying etiologiesAn observational studyMichelle T. McFarlane, Tom Wright, Blathnaid McCoy et al.Neurology, December 02, 2019